(Q37548575)

English

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension

scientific article published on 29 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension (English)

1 reference

Europe PubMed Central

21 August 2017

multiple sclerosis

0 references

Lixin Zhang-Auberson

9

object named as

Lixin Zhang-Auberson

0 references

Philipp von Rosenstiel

8

object named as

Philipp von Rosenstiel

0 references

3

object named as

Seiji Kikuchi

1 reference

Europe PubMed Central

21 August 2017

author name string

Jun-ichi Kira

1

1 reference

Europe PubMed Central

21 August 2017

Yasuto Itoyama

2

1 reference

Europe PubMed Central

21 August 2017

Qi Hao

4

1 reference

Europe PubMed Central

21 August 2017

Takayoshi Kurosawa

5

1 reference

Europe PubMed Central

21 August 2017

Kazuo Nagato

6

1 reference

Europe PubMed Central

21 August 2017

Isao Tsumiyama

7

1 reference

Europe PubMed Central

21 August 2017

Philipp von Rosenstiel

8

1 reference

Europe PubMed Central

21 August 2017

Lixin Zhang-Auberson

9

1 reference

Europe PubMed Central

21 August 2017

Takahiko Saida

10

1 reference

Europe PubMed Central

21 August 2017

publication date

29 January 2014

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

14

1 reference

Europe PubMed Central

21 August 2017

21

1 reference

Europe PubMed Central

21 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

29 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1471-2377-14-21

0 references

Genetic and infectious profiles of Japanese multiple sclerosis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

23 August 2017

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

23 August 2017

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

23 August 2017

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

23 August 2017

Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

23 August 2017

Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

23 August 2017

The non-Hodgkin lymphomas: a review of the epidemiologic literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

23 August 2017

Oral fingolimod (FTY720) for relapsing multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

23 August 2017

Revised diagnostic criteria for neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

23 August 2017

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

23 August 2017

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

6 September 2017

Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

25 June 2018

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

25 June 2018

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

1 September 2018

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

1 September 2018

Declaration of Helsinki. Ethical principles for medical research involving human subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3911956

1 September 2018

A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24475777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24475777

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2377-14-21

1 reference

Europe PubMed Central

21 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37548575&oldid=1861967694"